The Study of the Validation of General Evaluation Score (GES) in the Prediction of Hepatocellular Carcinoma Risk Among Patients With Advanced Fibrosis and Cirrhosis Who Achieved Sustained Virological Response for Hepatitis C Virus After Direct Acting Antiviral Drugs

Conditions: Hepatocellular Carcinoma Interventions: Diagnostic Test: General Evaluation Score (GES) Sponsors: Egyptian Liver Hospital Active, not recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials